3-4

(' )
.
. -
, .
( :)Pharmacokinetics ,
, , .
. . : ,
' . .
:
)ADME (Absorption, Distribution, Metabolism and Excretion
( ) . .

( :)Intermediate Steps of Drug Action ,

. . ,
( ,)Plasma Concentration Profile ( .)Site of Action
. 2 -:
.1 ( :)Pharmacokinetics
( ).
.2 ( :)Pharmacodynamics
,
.

 : ( ).
-PD . , .
:
.1 ' ().
.2 .
.3 , ?
:
(.)What the Body does to the Drug
(.)What the Drug does to the Body
( :)Drug Receptors (
) . /' .
" " . '
, - . '
.
, .
" ' ' , .
. ,' , DNA -,
' . (
).
' ( )Specific Interaction ,100% -
' .
'
GPCR .G protein 7
.
, ( Ion
)Channel /
, - .

:
:
.1 ( ) . ( )Insulin-Receptor .
( ) .
.2 - .
.3 , .
:
.1 . . .
- (.)Chrones
.2 ACE , , .Angiotensin-II 2
, .
DD .3 . .

 (:)Ion Channels
ATPase .1 .
.
2Cl .2 . , ,
Reuptake .
.3 , ( ) .
Ca-Influx , " , .
, .
:
.1 . .
, ( ) .
) Familial Mediterranean Fever( FMF .Gout -
/ .
.
: - ( .)Drug Receptor -
100 . / .'
. , ' '
' , () .
(!) , ( ." ).
, , -
. . ,
.
, .
" " ( , ') .
, ! .
.
: - . . -
? .
( ) (=) .
.
. . :
( ) ." ,
, . ?
, ( )Delay , !
, . " , .
( )Vagustoff" , " . .
? . "
" .
.
? .1 .2 .
( .)Binding Site 2:
. , , ,
. . , (
) , , ( .)Effector Site
( ').

 ( )Coupling
( )Signal Transduction Pathway .
' :
, .

? ( NSAIDs .)COX-Inhibitors
.


-.
2 :
.1.
.2

(


) .
.
PGH2 -
" 2
(
80%
).COX-2 , COX-1:
COX ,
2
.

:COX1/2 . COX1/2 523 COX1 -

(" ) COX2 - (" ) . . COX2 -
, , .

 COX1 - "" PGH2 - . , COX2 -

( ) (
COX1 ).
COX2 COX2 .COX1? COX2
COX1 : , , '.
, " .523
.

""

.
COX2

.
COX1 - COX2 -
/
.
,COX2

.

.
: , ,
COX1
.COX2

, , , .
() .
, .
. ,
.
" . = "
, (.)Saturation
, ,
:
( .)Saturation Plateau , ,
.100% -
,
.
.

 ( :)Hyperbola
.
50% -
"
( ).
( :)Logarithmic
( .)Sigmoid
,
( )data
. -
50% 11 -/".
( )Prototype
.
? ( )D , ()R
( .)DR . " (.)Law of Mass Action

:
.1 / .
.2 .
. ,
( .)Kd , Kd - . :

( , ) .
. ( .)Linear ,
, ( .)Maximal Response
- (.)Semi-Linear Response
100 60 , .
.60% "
." , ()f
.Kd : Kd -
( ).
Kd - 50%
.

 "" 50% ,
"" , ""
. , -
50% . Kd .
Kd . Kd -
. Kd - .
( :)Drug Efficacy
.

( ) .

.
( ) : Y -
( .)Drug Effect
50% ,
,Kd50 .)Effective Dose 50( ED50Emax -
.

. ,
. 1:1 Kd50
,ED50 - :
. Y
, Y .
, 50% -
50% -.

( ) .
. Emax.EC50 -

,
. . ' .
.n coefficient -
: 2 -
( .)Different Emax EC50 -
.

 .
( .)Full Agonist
(.)Partial Agonist

( )Antagonist
( ) .
, ( ) .
()Inverse Agonist
.

( :)Drug Potency
Emax .ED50 - , Efficacy
Potency - . .
ED50 .
ED50 represents potency, EMAX represents efficacy of a drug
: ( - )Opiates , "" .
3 , . ,
, () . , (
) .

( )Imodium .

. .)Emax( Efficacy

. ? ,
.
( ) ( Overdose
) . , , ,
.
( ) ,
.
, ( ) .
.

ED50 - .Emax - ,
( ).

 ( :)Equianalgesic Doses
.

: , .
, ( ) . (
) - ( ).

() : )1( - )2( - .
"" . . ,
.
,
50% . Emax - ,
,Right-Shift
. Shift - .
.ED50
: ( )C
( .)C
(( .)Degree of Antagonism -
ED50 'C- ED50-
.)C-

: Right Shift - (
Shift - ) . Ki - , Shift - ( ) . I
Ki- .

( Ki ) ,
, Emax . .
,Ki- 2 2
. -Ki 2 .
:
- .
- .
.
.
. right shift
.
.Emax

- : , .
. ,Emax efficiency- .

" .
, ,
.
.
" .

:
) )Phenoxybenzamine
- ,
.
.

.

+ , -
.
- .Emax-
- .
. .
.
: - COX1" .
() .
( ) . COX ,
!
. ,
, .
,
.
Spare Receptors
spare receptors :
.A -
,B ,right shift - .
( right shift .)C
.Emax
, , !
-.

 :
, .
. '
. .spare receptors
" " .
. (
,
).
,
( .)Emax ,Spare receptors ,
.
, 108 .
(
).
- :
- . . .
: , , , , ,
, ".
, . ,
. intrinsic activity- ( 0 .)0
, .
.
- , ,
." - ' .
. .
- . , .
( ) .
. ( )
.
: () ( , ) .
, ?
. ,
. :
( ) . , ,
. , .
. , - "
.

2 : , - . .
/ .

1- , 1- .
.
2- , 2- .

2- . ,
, " , ' . ,
. ( ).

: 1-
1-
.

, 1-
.
1-
" .
()
" . ,
.
:
2- , ( )
, .

Neurohumeral transmission
. (/)
- . .

 -
.G-Protein
( )coupling

" ' .

.
7 , -
( ) - ( ).
( ).

- ( ).
G Protein- . - GDP ,GTP '
. GTP GDP-
.

Desensitization
- : 1- .-2 80%
( ).
2- .
90% ,
, . - - .
.
- . ,
( - , ).

 -:
, " G( GRK ) ,
. ,
( .)coated pit . .
, - . .
- (=-):

, -
.
, (
) . .
. 8 ,
.

.
, ' -
, , ,
. ,
.
.
Beta-blockers
, .' .
- . .
. ( -
) , ,IV- / ' . " .
.
.

Pharmacogenetics
' . 20% " ,389 . '
.
.
" ,
. .
, .cAMP

 " , ,1-
' . ,
( )cAMP .
.cAMP
.

1- () -
. ,
,
.

( in-vitro) in-vivo ,"

.
() .
, , '.
Time delays in drug response
.
:
, .Cmax
.Tmax :
.

,
- .
, ( ) ,
. ,
( ) .
- ,
( t1 ,t2- ) ,
( .)t4,t5,t6
, ( )
.
,
. -
, . ,
. , 0- .
( ,lagging behind - )Hysteresis .

 :
.1 : , COX-

.

.
:Equilibrium delay .2
, .
. - ( :)sanctuary organs ,BBB
. , .
2:
. ,tight junctions -
. .
. .drug transporters - .
- , - .
. : . "
. " 6 .
:
- , T-Q" .
() .
, .
, , .
.
()
.
.
.3 , ,
.
: ( .)heat production
' .' ( )body temperature
, ( .)heat loss
' , .
' ,
.
- ( ):
,
- .
, -
.K K ,
. VKOR
.
1VKORC
K . -,

.

 , .
, . .
:
.
- -
.
( ) . -
.
?
, ,
. -
. , ,
. .
-/ . , ,
, ,
38- .
,
- .
.
- 38.0.
. ( 38- .)end point
. ,38- .
.
" . 100"
.800 500".
Frequency ,
. .
-
,100 200
200-
+100 .200 .

. ( ).

 .
.
,
.
-
( ).

.
- .

Y ,
() . Emax ,
100%.

. ,
. (
) ,
. 50%
.)effective dose( ED50
() .
50% .)lethal dose( LD50
:A . () ,
.
50% 50%-,
.
:B ,A
50% 50%
.
.

 -50LD , ( )
.
-TD50
, . ,
.

( - 2 ,
).
Therapeutic index
ED50 .TD50
50% ,

. .TD1 ED50
TD1 .therapeutic window
.

-INR , . INR .1
( ) , INR . ,
.
.
. . ,
( ) . .